Company intelligence / Profile preview

Ifars

Karanganyar, Jawa Tengah, Indonesia

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

PT Ifars Pharmaceutical Laboratories is a prominent Indonesian pharmaceutical manufacturer that produces a diverse portfolio of over 200 branded and generic medicines. The company operates high-capacity manufacturing facilities for solid, liquid, and semi-solid dosages, including dedicated beta-lactam lines for antibiotics.

Therapeutic areas: ImmunologyCardiovascularEndocrinologyNeurologyInfectious DiseasesRheumatologyPulmonologyGastroenterologyMen's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

PT Pradipta Adipacific

Beyond the preview

Go deeper on Ifars.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ifars.

Explore the full profile